SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-22-028070
Filing Date
2022-02-28
Accepted
2022-02-28 16:06:15
Documents
89
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10K cldx-20211231x10k.htm   iXBRL 10-K 2247407
2 EX-21.1 cldx-20211231xex21d1.htm EX-21.1 7153
3 EX-23.1 cldx-20211231xex23d1.htm EX-23.1 2324
4 EX-31.1 cldx-20211231xex31d1.htm EX-31.1 10129
5 EX-31.1 cldx-20211231xex31d2.htm EX-31.1 10510
6 EX-32 cldx-20211231xex32.htm EX-32 10760
12 GRAPHIC cldx-20211231x10k002.jpg GRAPHIC 38234
  Complete submission text file 0001104659-22-028070.txt   8423851

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA cldx-20211231.xsd EX-101.SCH 47011
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cldx-20211231_cal.xml EX-101.CAL 66336
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cldx-20211231_def.xml EX-101.DEF 232755
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cldx-20211231_lab.xml EX-101.LAB 510814
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cldx-20211231_pre.xml EX-101.PRE 405382
83 EXTRACTED XBRL INSTANCE DOCUMENT cldx-20211231x10k_htm.xml XML 1334735
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-15006 | Film No.: 22689341
SIC: 2835 In Vitro & In Vivo Diagnostic Substances